The human gut microbiota plays a crucial role in maintaining overall health, including
influencing various metabolic and immune functions. Recently, a growing body of research
has highlighted the significant relationship between gut microbiota composition and
cardiovascular health. This paper explores the emerging insights into how the gut microbiota
affects cardiovascular disease (CVD), its mechanisms of action, and potential therapeutic
strategies. The interaction between gut microbiota and cardiovascular health involves several
pathways, including gut-derived metabolites, immune modulation, and inflammation.
Additionally, we examine novel therapeutic approaches that leverage microbiota modulation,
such as probiotics, prebiotics, and fecal microbiota transplantation (FMT), as promising
interventions for cardiovascular disease prevention and management. Future research is
needed to further elucidate the complex relationship between the gut microbiota and
cardiovascular health, ultimately leading to innovative therapeutic options.
You may also start an advanced similarity search for this article.